ArticleCureus2026
Spectrum of Abnormal Uterine Bleeding in the Women of Sub-Himalayan Hilly Region of North India: Clinicodemographic Profile and Management Options.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Abnormal uterine bleeding (AUB) is one of the common complaints affecting women across different stages of life. Aim The aim of this study was to determine the AUB spectrum in our population and correlate it with the histopathological spectrum. Material and methods This is a hospital-based prospective cross-sectional study of women presenting with AUB. The baseline demographic data and clinical details of menstrual complaints were collected through a pre-validated, semi-structured proforma after taking informed consent. Endometrial biopsy was offered to all eligible women for histopathological confirmation of diagnosis and ruling out malignancy. Results A total of 260 women were enrolled. Heavy menstrual bleeding was the most common complaint (56.2%), followed by prolonged bleeding (16.9%), and irregular bleeding (18.4%). The histopathological results confirmed the diagnosis of secretory endometrium in 17.3%, proliferative endometrium in 49.2%, disordered proliferative endometrium in 25.4%, simple hyperplasia in 3.5%, endometrial polyp in 3.5%, and endometrial carcinoma in 1.2%. Majority of the women were classified as AUB-N (36.2%) according to the PALM-COEIN classification. Majority received medical management, either antifibrinolytic (98.5%), non-hormonal therapy (0.8%), or hormonal therapy in the form of oral progesterone (16.9%), combined oral contraceptive pills (1.9%), and levonorgestrel-releasing intrauterine contraceptive device (0.8%). Surgical management in the form of hysterectomy (20.8%) and hysteroscopy-guided endometrial polypectomy (1.9%) was also offered. Conclusion AUB affects women across all age groups, significantly affecting their quality of life. AUB-N, AUB-O and AUB-L contribute to a major proportion of AUB. A detailed evaluation, including histopathology, is required to rule out the associated cause and malignant/pre- malignant lesions of the endometrium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.